Li S, Liu Z, Lu C
BMC Nephrol. 2025; 26(1):123.
PMID: 40050799
PMC: 11884189.
DOI: 10.1186/s12882-024-03939-7.
Wang L, Hao M, Xu Y, Wang Z, Xie H, Zhang B
Stem Cell Res Ther. 2025; 16(1):111.
PMID: 40038808
PMC: 11881422.
DOI: 10.1186/s13287-025-04144-5.
Almaeen A, Saad-Eldien H, Gabr H
Int J Immunopathol Pharmacol. 2025; 39:3946320251315007.
PMID: 39921228
PMC: 11806471.
DOI: 10.1177/03946320251315007.
Su L, Jia Y, Li Y, Shi J
Inflamm Res. 2025; 74(1):22.
PMID: 39862302
DOI: 10.1007/s00011-025-02001-y.
Jo C, Lee S, Son Y, Lee W, Choe Y, Lee H
Animals (Basel). 2024; 14(22).
PMID: 39595338
PMC: 11591378.
DOI: 10.3390/ani14223283.
Myofibroblasts persist through immune privilege mechanisms to mediate oral submucous fibrosis: Uncovering the pathogenesis.
Sharma M, Shetty S, Soi S, Radhakrishnan R
J Oral Biol Craniofac Res. 2024; 14(6):773-781.
PMID: 39502133
PMC: 11535754.
DOI: 10.1016/j.jobcr.2024.10.008.
Impact of immunosuppressive drugs on efficacy of mesenchymal stem cell therapy for suppressing renal fibrosis.
Miyasako K, Nakashima A, Ishiuchi N, Tanaka Y, Morimoto K, Sasaki K
Stem Cells Transl Med. 2024; 13(11):1067-1085.
PMID: 39401338
PMC: 11555481.
DOI: 10.1093/stcltm/szae073.
Comparative study of systemic and local delivery of mesenchymal stromal cells for the treatment of chronic kidney disease.
Gregersen E, Kresse J, Atay J, Boysen A, Nejsum P, Eijken M
Front Cell Dev Biol. 2024; 12:1456416.
PMID: 39234562
PMC: 11373351.
DOI: 10.3389/fcell.2024.1456416.
Proteomic analysis and functional validation reveal distinct therapeutic capabilities related to priming of mesenchymal stromal/stem cells with IFN-γ and hypoxia: potential implications for their clinical use.
Calligaris M, Zito G, Busa R, Bulati M, Iannolo G, Gallo A
Front Cell Dev Biol. 2024; 12:1385712.
PMID: 38882056
PMC: 11179434.
DOI: 10.3389/fcell.2024.1385712.
Mesenchymal stem cells pretreated with interferon-gamma attenuate renal fibrosis by enhancing regulatory T cell induction.
Kurawaki S, Nakashima A, Ishiuchi N, Kanai R, Maeda S, Sasaki K
Sci Rep. 2024; 14(1):10251.
PMID: 38704512
PMC: 11069572.
DOI: 10.1038/s41598-024-60928-4.
Efficacy of IFN-γ-Primed Umbilical Cord-Derived Mesenchymal Stem Cells on Temporomandibular Joint Osteoarthritis.
Kim H, Kim Y, Yun S, Lee B
Tissue Eng Regen Med. 2024; 21(3):473-486.
PMID: 38190096
PMC: 10987468.
DOI: 10.1007/s13770-023-00620-2.
Comparison of the Therapeutic Effects of Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells on Renal Fibrosis.
Yoshida M, Nakashima A, Ishiuchi N, Miyasako K, Morimoto K, Tanaka Y
Int J Mol Sci. 2023; 24(23).
PMID: 38069242
PMC: 10706978.
DOI: 10.3390/ijms242316920.
Adipose-derived mesenchymal stem cells cultured in serum-free medium attenuate acute contrast-induced nephropathy by exerting anti-apoptotic effects.
Kadono M, Nakashima A, Ishiuchi N, Sasaki K, Miura Y, Maeda S
Stem Cell Res Ther. 2023; 14(1):337.
PMID: 37993965
PMC: 10664307.
DOI: 10.1186/s13287-023-03553-8.
Pansclerotic morphea is characterized by IFN-γ responses priming dendritic cell fibroblast crosstalk to promote fibrosis.
Xing E, Ma F, Wasikowski R, Billi A, Gharaee-Kermani M, Fox J
JCI Insight. 2023; 8(16).
PMID: 37471168
PMC: 10543736.
DOI: 10.1172/jci.insight.171307.
Mesenchymal stem cells and pulmonary fibrosis: a bibliometric and visualization analysis of literature published between 2002 and 2021.
Yang Y, Chen Y, Liu Y, Ning Z, Zhang Z, Zhang Y
Front Pharmacol. 2023; 14:1136761.
PMID: 37469875
PMC: 10352497.
DOI: 10.3389/fphar.2023.1136761.
Harnessing Biomaterials for Immunomodulatory-Driven Tissue Engineering.
Zhong J, Raghavan P, Desai T
Regen Eng Transl Med. 2023; 9(2):224-239.
PMID: 37333620
PMC: 10272262.
DOI: 10.1007/s40883-022-00279-6.
Comparison of therapeutic effects of mesenchymal stem cells derived from superficial and deep subcutaneous adipose tissues.
Ishiuchi N, Nakashima A, Maeda S, Miura Y, Miyasako K, Sasaki K
Stem Cell Res Ther. 2023; 14(1):121.
PMID: 37143086
PMC: 10161523.
DOI: 10.1186/s13287-023-03350-3.
Role of C-Reactive Protein in Kidney Diseases.
Li J, Chen J, Lan H, Tang Y
Kidney Dis (Basel). 2023; 9(2):73-81.
PMID: 37065607
PMC: 10090978.
DOI: 10.1159/000528693.
iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors.
Bogomiakova M, Sekretova E, Anufrieva K, Khabarova P, Kazakova A, Bobrovsky P
Stem Cell Res Ther. 2023; 14(1):77.
PMID: 37038186
PMC: 10088155.
DOI: 10.1186/s13287-023-03308-5.
Mechanisms of esophageal stricture after extensive endoscopic resection: a transcriptomic analysis.
Barret M, Doridot L, Le Gall M, Beuvon F, Jacques S, Pellat A
Endosc Int Open. 2023; 11(2):E149-E156.
PMID: 36741340
PMC: 9894697.
DOI: 10.1055/a-2000-8801.